H1N1 (Swine Flu) Vaccination Market

Q: How big was the global H1N1 (swine flu) vaccination market in 2024?

It was valued at US$ 2.2 Bn in 2024 Read More

Q: What is the projected size of the H1N1 (swine flu) vaccination market by 2035?

It is projected to cross US$ 4.1 Bn by the end of 2035 Read More

H1N1 (Swine Flu) Vaccination Market (Type: Inactivated and Attenuated; Route of Administration: Intramuscular, Intranasal and Intradermal) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025–2035

H1N1 (Swine Flu) Vaccination Market Outlook 2035

The global H1N1 (Swine Flu) Vaccination market size was valued at US $ 2.2 billion in 2024 and is projected to reach US $ 4.1 billion by 2035, expanding at a CAGR of 5.8% from 2025 to 2035. The market growth is driven by rising incidence of respiratory diseases and increased awareness of influenza pandemics

Market Size & Highlights

The H1N1 (Swine Flu) Vaccination market reached US $ 2.2 Billion in 2024.
The market is expected to climb to US $ 4.1 Billion by 2035.
The industry is anticipated to expand at a CAGR of 5.8% from 2025 to 2035.
Top companies in the market include MedImmune LLC, Sanofi Pasteur, Inc., GlaxoSmithKline (GSK), CSL, Bharat Biotech, Zydus Cadila, Sinovac Biotech, etc.
North America dominated the market in 2024, holding the largest revenue share of 37.7%.
By route of administration, the intramuscular segment held the major market share of 66.7% in 2024.

H1n1 (swine Flu) Vaccination Market By Revenue

Analysts’ Viewpoint regarding H1N1 (Swine Flu) Vaccination Market

The H1N1 (swine flu) vaccine market is influenced over the period of time by public health policy, progress pertaining to vaccines, and consumer perception. In the wake of the 2009 pandemic, the urgency of vaccination became more apparent to the public with the subsequent demand for H1N1 vaccines rising dramatically. In response to this trend, governments and health institutions worldwide acknowledged the pressing issue of being prepared for any eventual outbreak, which has invigorated vaccine makers to R&D activities.

Nevertheless, market conditions depend on numerous factors, such as vaccine effectiveness, public confidence, and the competition with the other influenza strains. The release of newer influenza strains has the effect of leaving no room for complacency as it always requires updated vaccines. The manufacturers thus have to remain vigilant.

Meanwhile, consumer behavior regarding vaccination has also been changing since the last few years with more people supporting the necessity of immunization against a disease that can be prevented. The change-up in the market presents the issues, which can both be used as jumping-off points for reaching new heights in the market. Eventually, the H1N1 vaccination market will be able to expand its horizons given there remains a steady effort in public health education and awareness coupled with a never-ending line of vaccine technology innovation.

H1N1 (Swine Flu) Vaccination Market Introduction

The H1N1 (swine flu) vaccine was devised in response to the pandemic caused by the H1N1 influenza virus in 2009. The vaccine has, since then, played a vital role in lessening the spreading of the virus, which is usually a younger population and the people with some kind of health problem. It is present as both - injectable and nasal spray, thus allowing the patients to select the one that suits them best. Health authorities like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) recommended vaccination as the most important way to stop the expansion of the epidemic.

The vaccine has gone through a set of tests to prove its safety and efficiency, thus rendering it conducive to the general public. To some extent, an initial reluctance of vaccination in certain population has been overcome by the vaccination campaigns, which have helped to increase uptake and improve community immunity. The implementation of the vaccine and the possible viral changes are being carefully observed through continuous monitoring and ongoing investigations. The findings emphasize vaccination as the primary tool for prevention of future influenza outbreaks.

Attribute	Detail
H1N1 (Swine Flu) Vaccination Market Drivers	Rising Incidence of Respiratory Diseases Increased R&D Investment Increased Awareness of Influenza Pandemics

Rising Incidence of Respiratory Diseases Expected to Drive H1N1 (Swine Flu) Vaccination Market Size

The growing occurrence of respiratory diseases is the major factor leading to the expansion of the H1N1 (swine flu) vaccine market. As cities grow and polluting factors worsen the air that people breathe, the number of individuals who are vulnerable to respiratory infections including influenza, keep rising. H1N1 is a virus that belongs to the flu family, and it is the one that causes the most trouble when the patients are those with weak immune systems, for example, children, old people, and people who have some kind of chronic illness.

Hospitals and clinics all over the world are gradually understanding that actions taken before the illness hits are very important to lessen the effects of respiratory diseases. Vaccination has been highly prioritized as the first and most effective instrument, which can be used to decrease the number of sick people and deaths resulting from viral outbreaks throughout the world. One of the methods to convince people to get vaccinated is through public health campaigns.

Moreover, the COVID-19 crisis has somehow attuned the public and health workers to the indispensable nature of vaccinations regimens as the first line of defense against pathogens. In addition, it also points to the necessity for H1N1 inoculation to be considered as a part of a complete respiratory disease treatment program. Consequently, the H1N1 vaccine market is projected to expand owing to the desire for the most reliable preventive measures against respiratory diseases and the continuous struggle to increase community immunity levels.

Increased R&D Investment Anticipated to Boost H1N1 (swine flu) Vaccination Market Expansion

Increasing research & development (R&D) expenditure is one of the major factors that has elevated the H1N1 (swine flu) vaccination industry. In an attempt to combat the spreading of the influenza viruses, especially after the 2009 pandemic, pharmaceutical companies and public health organizations have been compelled to allocate a large share of their budgets to the development of the new vaccines. The focus of such an investment is to improve the efficacy, safety, and delivery of vaccines, which also include the production of adjuvant vaccines and alternative formulations.

The viral nature of the flu is what calls for continuous research & development activities to ensure that the vaccines are still effective against new strains such as the H1N1. The implementation of the mRNA platforms and recombinant vaccines, which are examples of the advanced technologies, are the main propositions to facilitate the rapid response to the outbreaks. What is more, these innovations not only have positive effect on the effectiveness of the vaccines but the processing of their production is also simplified such that they can be distributed much faster in a pandemic situation.

Besides, these upsurges in the R&D efforts are mostly accompanied by the government grants and the public-private partnerships, which, in turn, increase the speed of generating a new H1N1 vaccine. Consequently, the market experiences a wave of vaccine candidates that are capable of solving not only the present but also the future problems of influenza.

Intramuscular Route of Administration Segment Driving H1N1 (swine flu) Vaccination Market Growth

H1n1 (swine Flu) Vaccination Market By Route

Intramuscular administration has been a major contributor to the expansion of the swine flu (H1N1) vaccine market, as it is a mode that has been proven both - effective and safe. Generally the immune responses triggered by the intramuscular administration of vaccines are strong, hence the body becomes more adept at recognizing and fighting off the H1N1 virus. Intramuscular injection is, in fact, a route that permits the vaccine to be absorbed in the blood circulating system. The immune system is thus the one that is the final target of the vaccine.

Furthermore, the intramuscular route is a method that is used in most clinical settings and it has been reported that not only healthcare providers but also patients are comfortable with it. The reduction in resistance to vaccines that results from the familiarity with the vaccine then becomes a factor responsible for the increase in vaccination rates among the population.

Besides, the intramuscular route is made possible for the use of larger volumes, thereby making the use of higher dosages in the case of vaccine formulations required for immunization be realized.

Regional Outlook of H1N1 (swine flu) Vaccination Market

H1n1 (swine Flu) Vaccination Market By Region

Attribute	Detail
Leading Region	North America

North America remains at the forefront of the H1N1 (swine flu) vaccination market holding the largest revenue share of 37.7%, towing to its combination of high levels of public health awareness, resilient healthcare infrastructure, and several government initiatives. Vaccination campaigns are facilitated by the region's robust healthcare systems, thus the access to vaccines is ensured for majority of the population. The high healthcare budget in the U.S. and Canada is also a major driver to the H1N1 vaccine development and distribution.

Public awareness of the necessity of vaccines has risen after the 2009 H1N1 pandemic, which, in turn, has led to a higher demand for flu vaccines. Vaccination is promoted by health organizations and government agencies as a very important preventive measure, thus leading to a higher immunization rate.

Furthermore, as far as North America is concerned, there is a heavy R&D funding on vaccine technologies, which leads to the production of more effective and safer H1N1 vaccines. The region is also home to the major pharmaceutical companies.

Besides, continuous attention to influenza and the other respiratory diseases, as a consequence of recent health crises worldwide, is what makes vaccination still at the top of the list. All these factors combined make North America a leader in the H1N1 vaccination market contributing to its growth and positive public health outcomes.

Analysis of Key Players in H1N1 (Swine Flu) Vaccination Market

MedImmune LLC, Sanofi Pasteur, Inc., GlaxoSmithKline (GSK), CSL, Bharat Biotech, Zydus Cadila, Sinovac Biotech, Serum Institute of India Pvt. Ltd. , ID Biomedical Corporation of Quebec are the key players governing the global H1N1 (swine flu) vaccination market.

Each of these players has been profiled in the H1N1 (swine flu) vaccination market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments in H1N1 (Swine Flu) Vaccination Market

In September 2025, WHO announced its 2026 influenza vaccine composition recommendations for the southern hemisphere, including the A/Missouri/11/2025 (H1N1)pdm09-like virus as one of the primary components. Trivalent and quadrivalent formulations were detailed, with B/Yamagata lineage being phased out.
In June 2025, Novavax, Inc. announced that its stand-alone seasonal influenza vaccine and a COVID-19/flu combination candidate produced robust immune responses (covering H1N1 among other strains) in a Phase 3 trial cohort.
In May 2025, The U.S. Department of Health and Human Services and the National Institutes for Health announced the Generation Gold Standard universal vaccine platform using BPL-inactivated whole virus.

H1N1 (swine flu) Vaccination Market Snapshot

Attribute	Detail
Size in 2024	US$ 2.2 Bn
Forecast Value in 2035	More than US$ 4.1 Bn
CAGR	5.8%
Forecast Period	2025-2035
Historical Data Available for	2020-2023
Quantitative Units	US$ Bn for Value
Market Analysis	It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis.
Competition Landscape	Competition Matrix Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format	Electronic (PDF) + Excel
Segmentation	By Type Inactivated Attenuated By Route of Administration Intramuscular Intranasal Intradermal By Age Group Pediatrics Adults Geriatric By Distribution Channel Public Private
Regions Covered	North America Europe Asia Pacific Latin America Middle East & Africa
Countries Covered	U.S. Canada Germany U.K. France Italy Spain The Netherlands China India Japan South Korea Australia ASEAN Brazil Mexico Argentina GCC Countries South Africa
Companies Profiled	MedImmune LLC Sanofi Pasteur, Inc. GlaxoSmithKline (GSK) CSL Bharat Biotech Zydus Cadila Sinovac Biotech Serum Institute of India Pvt. Ltd. ID Biomedical Corporation of Quebec Other Prominent Players
Customization Scope	Available upon request
Pricing	Available upon request

Frequently Asked Questions

How big was the global H1N1 (swine flu) vaccination market in 2024?

It was valued at US$ 2.2 Bn in 2024

What is the projected size of the H1N1 (swine flu) vaccination market by 2035?

It is projected to cross US$ 4.1 Bn by the end of 2035

What are the factors driving the H1N1 (swine flu) vaccination industry?

Rising incidence of respiratory diseases and increased awareness of influenza pandemics

What is the H1N1 (swine flu) vaccination market expected to grow during the forecast period?

It is anticipated to grow at a CAGR of 5.8% from 2025 to 2035

Which region is expected to dominate the H1N1 (swine flu) vaccination market during the forecast period?

North America is expected to account for the largest share from 2025 to 2035

Who are the prominent H1N1 (swine flu) vaccination providers?

MedImmune LLC, Sanofi Pasteur, Inc., GlaxoSmithKline (GSK), CSL, Bharat Biotech, Zydus Cadila, Sinovac Biotech, Serum Institute of India Pvt. Ltd. , ID Biomedical Corporation and others

Preface
- Market Definition and Scope
- Market Segmentation
- Key Research Objectives
- Research Highlights
Assumptions and Research Methodology
Executive Summary: Global H1N1 (swine flu) Vaccination Market
Market Overview
- Introduction
  - Segment Definition
- Overview
- Market Dynamics
  - Drivers
  - Restraints
  - Opportunities
- Global H1N1 (swine flu) Vaccination Market Analysis and Forecast, 2020-2035
  - Market Revenue Projections (US$ Bn)
Key Insights
- Porter’s Five Forces Analysis
- Value Chain Analysis
- PESTEL Analysis
- H1N1 (swine flu) Vaccination Market Overview
- Regulatory Framework Analysis
- Product Specification Analysis
- Distributor Landscape
- Market Ecosystem Analysis
- Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
- Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
- Go-to-Market Strategy for New Market Entrants
Global H1N1 (swine flu) Vaccination Market Analysis and Forecast, by Type
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Type, 2020-2035
  - Inactivated
  - Attenuated
- Market Attractiveness Analysis, by Type
Global H1N1 (swine flu) Vaccination Market Analysis and Forecast, by Route of Administration
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Route of Administration, 2020-2035
  - Intramuscular
  - Intranasal
  - Intradermal
- Market Attractiveness Analysis, by Route of Administration
Global H1N1 (swine flu) Vaccination Market Analysis and Forecast, by Age Group
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Age Group, 2020-2035
  - Pediatrics
  - Adults
  - Geriatric
- Market Attractiveness Analysis, by Age Group
Global H1N1 (swine flu) Vaccination Market Analysis and Forecast, by Distribution Channel
- Introduction & Definition
- Key Findings/Developments
- Market Value Forecast, by Distribution Channel, 2020-2035
  - Public
  - Private
- Market Attractiveness Analysis, by Distribution Channel
Global H1N1 (swine flu) Vaccination Market Analysis and Forecast, by Region
- Key Findings
- Market Value Forecast, by Region, 2020-2035
  - North America
  - Europe
  - Asia Pacific
  - Latin America
  - Middle East & Africa
- Market Attractiveness By Country/Region
North America H1N1 (swine flu) Vaccination Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2020-2035
  - Inactivated
  - Attenuated
- Market Value Forecast, by Route of Administration, 2020-2035
  - Intramuscular
  - Intranasal
  - Intradermal
- Market Value Forecast, by Age Group, 2020-2035
  - Pediatrics
  - Adults
  - Geriatric
- Market Value Forecast, by Distribution Channel, 2020-2035
  - Public
  - Private
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - U.S.
  - Canada
- Market Attractiveness Analysis
  - By Type
  - By Route of Administration
  - By Age Group
  - By Distribution Channel
  - By Country/Sub-region
Europe H1N1 (swine flu) Vaccination Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2020-2035
  - Inactivated
  - Attenuated
- Market Value Forecast, by Route of Administration, 2020-2035
  - Intramuscular
  - Intranasal
  - Intradermal
- Market Value Forecast, by Age Group, 2020-2035
  - Pediatrics
  - Adults
  - Geriatric
- Market Value Forecast, by Distribution Channel, 2020-2035
  - Public
  - Private
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - The Netherlands
  - Rest of Europe
- Market Attractiveness Analysis
  - By Type
  - By Route of Administration
  - By Age Group
  - By Distribution Channel
  - By Country/Sub-region
Asia Pacific H1N1 (swine flu) Vaccination Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2020-2035
  - Inactivated
  - Attenuated
- Market Value Forecast, by Route of Administration, 2020-2035
  - Intramuscular
  - Intranasal
  - Intradermal
- Market Value Forecast, by Age Group, 2020-2035
  - Pediatrics
  - Adults
  - Geriatric
- Market Value Forecast, by Distribution Channel, 2020-2035
  - Public
  - Private
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - China
  - India
  - Japan
  - South Korea
  - ASEAN
  - Australia
  - Rest of Asia Pacific
- Market Attractiveness Analysis
  - By Type
  - By Route of Administration
  - By Age Group
  - By Distribution Channel
  - By Country/Sub-region
Latin America H1N1 (swine flu) Vaccination Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2020-2035
  - Inactivated
  - Attenuated
- Market Value Forecast, by Route of Administration, 2020-2035
  - Intramuscular
  - Intranasal
  - Intradermal
- Market Value Forecast, by Age Group, 2020-2035
  - Pediatrics
  - Adults
  - Geriatric
- Market Value Forecast, by Distribution Channel, 2020-2035
  - Public
  - Private
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Market Attractiveness Analysis
  - By Type
  - By Route of Administration
  - By Age Group
  - By Distribution Channel
  - By Country/Sub-region
Middle East & Africa H1N1 (swine flu) Vaccination Market Analysis and Forecast
- Introduction
  - Key Findings
- Market Value Forecast, by Type, 2020-2035
  - Inactivated
  - Attenuated
- Market Value Forecast, by Route of Administration, 2020-2035
  - Intramuscular
  - Intranasal
  - Intradermal
- Market Value Forecast, by Age Group, 2020-2035
  - Pediatrics
  - Adults
  - Geriatric
- Market Value Forecast, by Distribution Channel, 2020-2035
  - Public
  - Private
- Market Value Forecast, by Country/Sub-region, 2020-2035
  - GCC Countries
  - South Africa
  - Rest of Middle East & Africa
- Market Attractiveness Analysis
  - By Type
  - By Route of Administration
  - By Age Group
  - By Distribution Channel
  - By Country/Sub-region
Competition Landscape
- Market Player - Competition Matrix (By Tier and Size of Companies)
- Market Share Analysis, by Company (2024)
- Company Profiles
  - MedImmune LLC
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Sanofi Pasteur, Inc.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - GlaxoSmithKline (GSK)
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - CSL
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Bharat Biotech
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Zydus Cadila
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Sinovac Biotech
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - Serum Institute of India Pvt. Ltd.
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments
  - ID Biomedical Corporation of Quebec
    - Company Overview
    - Financial Overview
    - Product Portfolio
    - Business Strategies
    - Recent Developments

List of Tables

Table 01: Global H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 02: Global H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 03: Global H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 04: Global H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 05: Global H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 06: North America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
Table 07: North America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 08: North America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 09: North America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 10: North America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 11: Europe H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 12: Europe H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 13: Europe H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 14: Europe H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 15: Europe H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 16: Asia Pacific H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 17: Asia Pacific H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 18: Asia Pacific H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 19: Asia Pacific H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 20: Asia Pacific H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 21: Latin America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 22: Latin America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 23: Latin America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 24: Latin America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 25: Latin America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035
Table 26: Middle East & Africa H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 27: Middle East & Africa H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 28: Middle East & Africa H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Route of Administration, 2020 to 2035
Table 29: Middle East & Africa H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 30: Middle East & Africa H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, By Distribution Channel, 2020 to 2035

List of Figures

Figure 01: Global H1N1 (swine flu) Vaccination Market Value Share Analysis, By Type, 2024 and 2035
Figure 02: Global H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 03: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Inactivated, 2020 to 2035
Figure 04: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Attenuated, 2020 to 2035
Figure 05: Global H1N1 (swine flu) Vaccination Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 06: Global H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 07: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Intramuscular, 2020 to 2035
Figure 08: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Intranasal, 2020 to 2035
Figure 09: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Intradermal, 2020 to 2035
Figure 10: Global H1N1 (swine flu) Vaccination Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 11: Global H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 12: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Pediatrics, 2020 to 2035
Figure 13: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Adults, 2020 to 2035
Figure 14: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Geriatric, 2020 to 2035
Figure 15: Global H1N1 (swine flu) Vaccination Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 16: Global H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 17: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Public, 2020 to 2035
Figure 18: Global H1N1 (swine flu) Vaccination Market Revenue (US$ Bn), by Private, 2020 to 2035
Figure 19: Global H1N1 (swine flu) Vaccination Market Value Share Analysis, By Region, 2024 and 2035
Figure 20: Global H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 21: North America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 22: North America H1N1 (swine flu) Vaccination Market Value Share Analysis, by Country, 2024 and 2035
Figure 23: North America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 24: North America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Type, 2024 and 2035
Figure 25: North America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 26: North America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 27: North America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 28: North America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 29: North America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 30: North America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 31: North America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 32: Europe H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 33: Europe H1N1 (swine flu) Vaccination Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 34: Europe H1N1 (swine flu) Vaccination Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 35: Europe H1N1 (swine flu) Vaccination Market Value Share Analysis, By Type, 2024 and 2035
Figure 36: Europe H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 37: Europe H1N1 (swine flu) Vaccination Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 38: Europe H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 39: Europe H1N1 (swine flu) Vaccination Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 40: Europe H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 41: Europe H1N1 (swine flu) Vaccination Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 42: Europe H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 43: Asia Pacific H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 44: Asia Pacific H1N1 (swine flu) Vaccination Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 45: Asia Pacific H1N1 (swine flu) Vaccination Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 46: Asia Pacific H1N1 (swine flu) Vaccination Market Value Share Analysis, By Type, 2024 and 2035
Figure 47: Asia Pacific H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 48: Asia Pacific H1N1 (swine flu) Vaccination Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 49: Asia Pacific H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 50: Asia Pacific H1N1 (swine flu) Vaccination Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 51: Asia Pacific H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 52: Asia Pacific H1N1 (swine flu) Vaccination Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 53: Asia Pacific H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 54: Latin America H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 55: Latin America H1N1 (swine flu) Vaccination Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 56: Latin America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 57: Latin America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Type, 2024 and 2035
Figure 58: Latin America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 59: Latin America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 60: Latin America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 61: Latin America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 62: Latin America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 63: Latin America H1N1 (swine flu) Vaccination Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 64: Latin America H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035
Figure 65: Middle East & Africa H1N1 (swine flu) Vaccination Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 66: Middle East & Africa H1N1 (swine flu) Vaccination Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 67: Middle East & Africa H1N1 (swine flu) Vaccination Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 68: Middle East & Africa H1N1 (swine flu) Vaccination Market Value Share Analysis, By Type, 2024 and 2035
Figure 69: Middle East & Africa H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 70: Middle East & Africa H1N1 (swine flu) Vaccination Market Value Share Analysis, By Route of Administration, 2024 and 2035
Figure 71: Middle East & Africa H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Route of Administration, 2025 to 2035
Figure 72: Middle East & Africa H1N1 (swine flu) Vaccination Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 73: Middle East & Africa H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 74: Middle East & Africa H1N1 (swine flu) Vaccination Market Value Share Analysis, By Distribution Channel, 2024 and 2035
Figure 75: Middle East & Africa H1N1 (swine flu) Vaccination Market Attractiveness Analysis, By Distribution Channel, 2025 to 2035